@xconomy.com 3 months ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com 3 months ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com 9 months ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill